Progyny, Inc. Income (Loss) from Continuing Operations, Per Basic Share
Progyny, Inc. (PGNY) reported Income (Loss) from Continuing Operations, Per Basic Share of $0.59 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2025-03-03
- Progyny, Inc. income (loss) from continuing operations, per basic share for fiscal 2024 was $0.59, a 9.23% decline from fiscal 2023.
- Progyny, Inc. income (loss) from continuing operations, per basic share for fiscal 2023 was $0.65, a 96.97% increase from fiscal 2022.
- Progyny, Inc. income (loss) from continuing operations, per basic share for fiscal 2022 was $0.33, a 55.41% decline from fiscal 2021.
- Progyny, Inc. income (loss) from continuing operations, per basic share for fiscal 2021 was $0.74, a 37.04% increase from fiscal 2020.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|
| 2024-12-31 | $0.59 10-K · filed 2025-03-03 |
| 2023-12-31 | $0.65 10-K · filed 2025-03-03 |
| 2022-12-31 | $0.33 10-K · filed 2025-03-03 |
| 2021-12-31 | $0.74 10-K · filed 2024-02-29 |
| 2020-12-31 | $0.54 10-K · filed 2023-03-01 |
| 2019-12-31 | -$0.41 10-K · filed 2022-03-01 |
| 2018-12-31 | -$1.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |